| Literature DB >> 35458783 |
Daria-Antonia Dumitraș1, Sanda Andrei1.
Abstract
Although conventional medicine, chemical drug synthesis and pharmaceutical research are advancing at a rapid pace, nature remains a major supplier of biological molecules. Natural bioactive compounds are studied closely especially as an alternative to the limitations of conventional therapy in many diseases, melanoma being one of them. Malignant melanoma is a highly aggressive type of cancer, and the current methods of treatment used are cryotherapy, external surgery, radiation therapy, chemotherapy, photodynamic therapy, biological therapy, and targeted drug therapy. Unfortunately, these treatment methods are often inefficient, extremely expensive and cause many side effects, which is why focusing on melanoma chemoprevention and adjuvant therapy with natural herbal phytoconstituents is an emerging strategy to prevent, cure or treat melanoma. This review aims to examine the latest discoveries in terms of potential natural bioactive compounds that possess important activity against the development and spread of murine melanoma cancer. In particular, the use of different phytochemicals such as phenolic acids, flavonoids, anthocyanins, terpenoids, essential oils and carotenoids in vitro and in vivo models will be discussed. These data are helpful in guiding researchers in the direction of studying phytonutrients with important effects in the prevention and treatment of melanoma.Entities:
Keywords: bioactive compounds; in vitro; in vivo; malignant melanoma; phytotherapy
Mesh:
Substances:
Year: 2022 PMID: 35458783 PMCID: PMC9028509 DOI: 10.3390/molecules27082585
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Bioactive compounds tested against B16F10 murine melanoma.
| No. | Plant Name | Common Name | Part Used | Type of Extract | Most Important Bioactive Components | Dose Concentration | Mechanism | Reference |
|---|---|---|---|---|---|---|---|---|
| Bioactive Compounds Tested In Vitro | ||||||||
|
| ||||||||
|
|
| Branched scouringrush | Whole plant | Ethyl acetate, | Polyphenols | 5, 50, 100, and 200 μg/mL | activation of caspase-3 and -9; tyrosinase suppression; MITF, Trp-1, and Trp-2 regulation | [ |
|
| Maltese Mushroom | Whole plant | Aqueous extract | cyanidin 3- | 25 to 500 μg/mL | anti-tyrosinase activity; | [ | |
|
| Autumn squash, marrow, pumpkin, turban gourd, buttercup squash | Hull-less pumpkin (HLP) and hull pumpkin (HP) | Ethanolic extracts | Coumaric acid | HLP polyphenols extract (10, 20, 40, 60, 80, 100, 200, 400, 600, 800, or 1000 μg/mL) | ↓ tyrosinase; ↓ intracellular melanin | [ | |
|
| Horseradish tree; | Leaves and seeds | Aqueous extracts | Not mentioned | 2 mg/mL | ↑ G2/M phase; arrest of the cell cycle in G1 phase; ↑ p53; ↑ p21WAF1/Cip1; | [ | |
|
| Common lilac | Flowers, leaves, bark and fruit | Ethanolic extracts | Acteoside and echinacoside; ligstroside, syringalactone A, oleuropein-aglycone. | leaves (11.34–56.7 µmol GAE/mL), fruit (6.66–33.2 µmol GAE/mL), bark (9.875–49.37 µmol GAE/mL) and flowers (11.69–58.475 µmol GAE/mL) | Antioxidant and cytotoxic activity | [ | |
|
|
| Spiny Holdback, Tara | Whole plant | Ethanolic extract | P2Et | 72.1 μg/mL | ↑ cell death; inducing of autophagy | [ |
|
|
| Rose of Jericho | Root and leaves | Methanolic extract | kaempferol, luteolin, quercetin | 200–1000 μg/mL | ↓ mitochondrial membrane potential; ↓ GSH; ↓ ROS; | [ |
|
|
| White forsythia | Leaves | Methanolic extract | acteoside, eutigoside B, isoacteoside, rutin, cornoside, hirsutrin, chlorogenic acid, caffeic acid, gentisic acid, ferulic acid, and quercetin | 50–200 µg/mL | ↑ ROS in cancer cells; ↑ caspase −3 and −9; ↓ Bax/Bcl-2 ratio; activation of MEK 1/2 and ERK 1/2 | [ |
|
| Date palm | Seeds | Aqueous extract | Ferulic acid | 0.245 and 0.49 (mg/mL) | ↓ ROS; ↓ melanogenesis signal proteins: p-p38, p-JNK, p-ERK, and p-CREB; | [ | |
|
| Oregano | Whole plant | Hydroalcoholic | Chrysin, quercetin-3- | 10 mg/mL | mitochondria and DNA damage; ↑ the number of cells in G2/M phase; ↓ expression of CCNB1 and CDK1 genes; | [ | |
|
|
| Beachstar | Whole plant | Hydroalcoholic extract | Vitexin, isovitexin and luteolin | 0.1–100 μg/mL | hydroxyl radicals scavenging; | [ |
|
| Spanish broom, weaver’s broom | Flowers | Aquaeous extracts and Hydroalcoholic extract | Multiple polyphenols | 2, 4, 6, 8, 10 HFE mg/mL | ↓ cell proliferation | [ | |
|
|
| Mistletoe | Whole plant | Ethanolic extract | caffeic acid, | 1 to 5% | DNA fragmentation; ↑ Sub G0 population; ↑ S and G2/M populations; | [ |
|
| ||||||||
|
|
| Purple shiso, Chinese basil and purple perilla. | Leaves | Ethanolic extract | Apigenin and sinensetin | 25 µg/mL Pfc 5 | ↓ tyrosinase activity; ↓ LPS-induced pro-inflammatory genes | [ |
|
|
| Pomegranate | Peel | Ethanolic extract | Kaempferol, luteolin, quercetin and proanthocyanidin, complex polysaccharides. hydrolyzable tannins (ellagitannin, punicalagin, punicalin and pedunculagin). | 10–450 µg/mL | ↓ cell | [ |
|
|
| Blunt-Lobed Spicebush | Leaves | Methanolic extract | Quercitrin and afzelin | 100–1000 µg/mL | ↓ tyrosinase activity; ↓ melanin synthesis; ↓ MITF and tyrosinase proteins; activation of MAP kinase pathway | [ |
|
|
| Flax-leaved daphne | Leaves | Aqueous extract | Daphnetin and luteolin-7-glucoside | 70 μM of luteolin-7- glucoside and daphnetin | activation of caspase 3; inducing sub-G1 cell cycle arrest; | [ |
|
| ||||||||
|
|
| Elderberry | Fruits | Aqueous extract | Cy-3- | 250 µg/mL | ↑ LDH; detachment, rounding up, shrinkage, and blebbing of membrane and apoptotic bodies; | [ |
|
| Low-bush blueberryes | Fruits | Hydroalcoholic extract | Anthocyanins and anthocyanidins | 12.5–800 μg/mL | Blockage of cell cycle procession at the G0/G1 phase; down-regulation of cyclin D1 expression; ↓ caspase-3 and p53; | [ | |
|
| Blueberry | Fruits | Methanolic extract | Delphinidin glycosides, cyanidin glycosides, petunidin glycosides | 200–750 μg/mL | ↑ LDH, cell detachment, rounding up and shrinkage, | [ | |
|
| Blueberry and blackcurrants | Fruit juice | Methanolic extract | delphinidin-3- | 0–500 μg/mL (blueberry); | Antiproliferative effect | [ | |
|
| ||||||||
|
| Black and long pepper | Fruits | Not Mentioned | Piperine | Not Mentioned | G1 Phase Cell Cycle Arrest; ↑ ROS in tumor cells | [ | |
|
| ||||||||
|
| Malus domestica Borkh | Apple pomace | Dried apple pomace | Enzymatic preparations | Pectin | 1 mg/mL | ↓ adhesion, proliferation and cell invasion; | [ |
|
|
| Chaga | Fruits | Aqueous extracts | Polysaccharide | 1–1000 μg/mL | ↓ MMP-2 and MMP-9; ↓ NF-κB signaling pathway; ↓ migration ability | [ |
|
| ||||||||
|
|
| Beautyberry | Leaves | Ethanolic extract | Carnosol and carnosic acid | 10 μg/mL | ↓ MITF gene expression | [ |
|
|
| Red Macroalgae, Tengusa, makusa, genso. | Whole plant | Ethanolic extract | Brassicolene | 100–200 µg/mL | ↓ Bcl2; ↑ p53, Bax, | [ |
|
| Common olive | Olive pomace | Not mentioned | Maslinic acid | 0 to 212 µM | ↓ ROS; | [ | |
|
|
| Black sea cucumber, black tarzan | Body wall | Ethanolic extract | Saponin | (0, 4, 8, 12, 16, 20 μg/mL) and dacarbazine (0, 1200, 1400, 1600, 1800, 2000 μg/mL) | ↑cells in sub-G1 peak; activation of caspse-3 and caspase-9; | [ |
|
|
| Plantains or fleaworts | Whole plant | Ethanolic extract | Aucubin and iridoid glycoside | 0.6, 1.2, 2.5 and 5 µg/mL | Apoptosis with cell morphology changes | [ |
|
|
| Hemp, grass, hashish, | Flowers and leaves | CO2 and standardized based on 4% cannabidiol | Cannabidiol | 25, 12.5, and 6.25 µg/mL | ↓cell viability | [ |
|
| ||||||||
|
|
| Wild sage | Leaves | Essential oil | α-zingiberene | 10 mg/mL | cytotoxic activity | [ |
|
| ||||||||
|
|
| Indian prickly ash | Bark | Methanolic extract | Yangambin and kobusin, columbamine and lupeol | 500, 250, 125, 62.5, 31.25, 15.625, 7.81 µg/mL | Cytotoxicity | [ |
|
|
| Azarole, azerole, and Mediterranean medlar. | Leaves | Ethyl acetate extract | Ursolic acid and vitexin-2′’- | 400 µg/mL | ↓ cell proliferation | [ |
|
| Organ-pipe cactus | Stem | Hexane, chloroform, | Not mentioned | 0.03 to 500 µg/mL | Cytotoxicity | [ | |
|
| ||||||||
|
| ||||||||
|
|
| Green propolis | Whole plant | Hydroalcoholic extract | Baccharin and p-coumaric acid | 500 μg/kg | ↓ cell mitosis; ↓ angiogenesis; | [ |
|
| ||||||||
|
|
| Flax-leaved daphne | Leaves | Aqueous extract | Daphnetin and luteolin-7-glucoside | 200 mg/kg for 21 days | ↓ tumor growth; restoration of the proliferation of splenic lymphocytes; | [ |
|
| ||||||||
|
|
| Indian tobacco | Bark | Ethanolic extracts | Alkaloids | 300 mg/kg, orally administered, for 30 days | ↓ tumor growth; ↓ IL-1, IL-6 and TNF-α | [ |
|
| ||||||||
|
| Misteltoe | Whole plant | Aqueous extract | oleanolic acid | 12 µg/kg ML-I | ↓ angiogenesis; ↑ caspase-3; | [ | |
|
| ||||||||
|
| Orchid tree | leaves, stem bark and floral buds | Hydro-methanolic extract | alkaloids, flavonoids, tannins, terpenoids and glycosides | 500 and 750 mg/kg | ↓ tumor volume; ↑ GSH; | [ | |
|
| ||||||||
|
| ||||||||
|
| Turmeric | Rhizomes | Not mentioned | Curcumin | 1.10–270 µM | Modulation of BCl2, MAPKS, p21 and some microRNAs; NF-jB, IKKmodulation | [ | |
|
|
| Athena Sendtn. | Leaves | Organic solvent mixture (dichloromethane/methanol, 1:1) and distilled water | quinic acid, and its caffeic acid | 1.562–200 μg/mL; | ↓ migration, adhesion, invasion and cell colony formation | [ |
| 100 mg/kg bw, daily, for 21 days | ||||||||
|
|
| Purple gromwell; red gromwell | Roots | Hexane extract | Shikonin; Deoxyshikonin; b-Hydroxyisovalerylshikonin; Acetylshikonin and Isobutyrylshikonin | 0, 0.5, 1, 2, 3 and 4 µg/mL | activation of caspase 3; inducing sub-G1 cell cycle arrest; ↓ Bcl-2 | [ |
| 10 mg/kg/day, 21 days | ||||||||
|
|
| Gingseng | Whole plant | Ethanolic extract | Polyacetylenes and polyphenolics | 0.3, 1.0, 3.0, or 10.0 µg/mL | Activation of caspase-8 and -9; inhibition of transcription of MMP-2 DNA; | [ |
| Orally administration of 300 and 1000 mg/kg in 0.2 mL of 4% ethanol solution once per day for 13 days | ||||||||
|
| ||||||||
|
|
| Hawthorn, Zâarour | Leaves | Aqueous extract | (−)-epicatechin (EC) | 400 µg/mL (in vitro) | ↓ intracellular melanin; | [ |
|
|
| Turmeric | Rhizome | Aqueous extract encapsulated | Curcumin and chrysin | pure Cur-Chr mixture (CurChr) (each of them 5, 10, 15, 20, 30, 40, 50 and 60 lM) and equivalent concentrations of encapsulated Chr and Cur mixture (CurChr NPs) | ↓ MMP-9, MMP-2 and TERT genes expressions; ↑ TIMP-1 and TIMP-2; ↓ tumor growth; | [ |
| pure Cur (15 mg/kg), | ||||||||
|
|
| Miyagawa mandarin, unshu mikan | Peel | Ethanolic extracts | Naringin and hesperidin | 0, 20, 40, 60, 80, and 100 μg/mL | ↓ mitochondrial membrane potential; ↑ LDH; ↑ ROS; ↓ migration, invasion, and colony formation | [ |
| 100 μL of 100 mg/kg/day; 100 μL of 200 mg/kg/day for 21 days | ↓ LDH, ↓ lung hypertrophy, the number and expression of metastatic tumor nodules | |||||||
|
| ||||||||
|
|
| Chinese angelica, the garden angelica, root of the Holy Ghost | Root | Ethanolic extract | Coumarine and pyrrole 2-carbaldedhyde | 100 μL of EEAD | ↑ Bax/Bcl-2 expression | [ |
| 100 mg/kg/day; 100 μL of EEAD 200 mg/kg/day | ↓ LDH | |||||||
|
| ||||||||
|
|
| Lang-Du | Root | Not mentioned | Jolkinolide B | 20, 40 and 60 μM | ↑ mRNA level of Bax | [ |
| 10, 20 and 40 mg/Kg | ↓ mRNA levels of Bcl-2 and Caspase9 | |||||||
|
| Japanese ginseng | Not Mentioned | Not Mentioned | Ginsenoside Ro- Zingibroside R1, chikusetsusaponin IVa, and calenduloside E (Ro metabolites) | 0, 1, 3, 10, 30, and 100 µg/mL | Without cytotoxic effect in vitro | [ | |
| 25 mg/kg i.p., 15 days | ↓ tumor weight; anti-angiogenic activity | |||||||
|
|
| Common juniper | Not Mentioned | Distillation | α-Pinene, citronellyl acetate, and d-limonene | 0–100 μg/mL | anoikis, chromatin condensation, DNA fragmentation, and the appearance of apoptotic bodies; ↓ bcl-2 and procaspase-9; ↑ bax; ↑ Fas and FasL expression; ↓ procaspase-3 and -8; | [ |
| 200 mg/kg, sc, every 2 days, for 14 days | ↓ tumor growth; ↑ survival rate | |||||||
|
|
| Cedar of Lebanon | Wood | Hexane extracts | Himachalol | 1, 5, 10, 15 and 25 μg/mL | ↑ sub-G1 phase | [ |
| 0.2 mL- topical administration, 0.02 mL of 7-HC, 50 mg/kg, diluted in sunflower oil—gavage administration, 0.1 mL dissolved in DMSO (10, 25, or 50 mg/kg)- ip administration | ↓ tumor volume | |||||||
|
| ||||||||
|
| Various plants | Various names | Various Parts of the Plants | Various types of Extract | Cyanidin (Cyanidin-3- | Various doses | ↓ tumor growth; ↓ cell proliferation; ↓ viability; | [ |
|
| Various Plants | Various names | Various Parts of the Plants | Various Types of Extract | Multiple Compounds | Various Doses | ↓ MMP-2 and MMP-P expressions | [ |
|
|
| Mexican Loosestrife | Aerial parts | methanolic and aqueous extracts | phenols, terpenes, steroids, and saponins | aqueous (0.05, 0.1, 0.2, 0.4, 0.6, 0.8 mg/mL) and methanolic extracts (0.0425, 0.085, 0.17, 0.34, 0.51, 0.68 mg/mL) | ↑ cells in G1 phase; cytoplasm shrinkage; DNA fragmentation; | [ |
| 25 mg/mL, in water, for 14 days | ↓ tumor volume | |||||||
|
| 370 plants | Various Names | Various Parts of the Plants | Various Types of Extract | Multiple Compounds | Various Doses | ↓ cell proliferation | [ |
|
|
| Maidenhair tree | Exocarp | Ethanolic extract | Proteoglycan | 5–320 µg/mL | regulation of PI3K/Akt/NF-kB/MMP-9 signaling pathway | [ |
| 50–200 mg/kg | ||||||||
|
|
| Flamevine or orange trumpetvine | Flowers | Heptane extract | Octacosane and triacontane | Not Mentioned | disruption of the mitochondrial membrane potential and ↑ ROS; activation of caspase-2, -3, -8, -9; cell cycle arrest at G2/M | [ |
|
| ||||||||
|
|
| Brown algae | Whole plant | Not Mentioned | Fucoxanthin | Not Mentioned | Modulation of Bcl-2 proteins, MAPK, NFκB, Caspases, GADD45; cell cycle arrest in the G0/G1; DNA fragmentation; ↓ MMP-9; ↓ tumor growth; | [ |
|
|
| Brown algae | Whole plant | Not Mentioned | Fucoxanthin | 50, 100, and 200 µM | induction of cell cycle arrest during the G0/G1 phase and apoptosis; ↓ Rb; ↓ cyclin D (1 and 2); ↓ CDK; ↑ p15INK4B and p27Kip; ↓ Bcl-xL; ↑ caspase-9, caspase-3, and PARP | [ |
| 300 µg/100 µL/mouse adm. ip, every 5 days | ||||||||
|
| ||||||||
|
|
| Yeast | Seeds | Water extract | Pisum sativum defensin | 0, 3.12, 6.25, 12.5, 25, or 50 µM for 24, 48, or 72 h | ↑ sub-G0/G1; DNA fragmentation; | [ |
| 0.1–3 mg/kg | ||||||||